SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Iteris, Inc. - ITI
Iteris (Nasdaq: ITI) is the subject of a shareholder investigation by Monteverde & Associates regarding its proposed merger with Almaviva S.p.A. Under the merger agreement, Iteris shares will be converted into the right to receive $7.20 in cash per share. The investigating firm notes it has recovered money for shareholders in past cases and offers a free review with no obligation.
Investors should note the proposed
Iteris (Nasdaq: ITI) è oggetto di un'indagine azionisti da parte di Monteverde & Associates riguardo alla sua proposta di fusione con Almaviva S.p.A. Secondo l'accordo di fusione, le azioni Iteris saranno convertite nel diritto di ricevere $7.20 in contanti per azione. L'ente di indagine nota di aver recuperato denaro per gli azionisti in casi passati e offre una revisione gratuita senza obbligo.
Gli investitori dovrebbero notare la proposta $7.20 di contanti e che è attiva un'indagine da parte di terzi, la quale potrebbe influire sui tempi dell'accordo o sui rimedi per gli azionisti.
Iteris (Nasdaq: ITI) es objeto de una investigación de accionistas por parte de Monteverde & Associates con respecto a su fusión propuesta con Almaviva S.p.A. Según el acuerdo de fusión, las acciones de Iteris se convertirán en el derecho a recibir $7.20 en efectivo por acción. La firma investigadora señala que ha recuperado dinero para accionistas en casos anteriores y ofrece una revisión gratuita sin obligación.
Los inversores deben tener en cuenta la propuesta de $7.20 en efectivo y que está activa una investigación independiente, lo que podría afectar el momento del acuerdo o los recursos disponibles para los accionistas.
Iteris(나스닥: ITI)는 Almaviva S.p.A.와의 제안된 인수합병에 관한 Monteverde & Associates의 주주 조사를 받고 있습니다. 인수합병 계약에 따라 Iteris의 주식은 주당 $7.20 현금 수령 권리로 전환됩니다. 조사 기관은 과거에도 주주들을 위한 금액을 회수한 이력이 있으며 의무 없는 무료 검토를 제공합니다.
투자자들은 $7.20 현금 보상의 제안과 제3자 조사가 활발히 진행 중이라는 점에 유의해야 하며, 이는 거래 시기나 주주 구제책에 영향을 미칠 수 있습니다.
Iteris ( Nasdaq : ITI ) fait l'objet d'une enquête d'actionnaires menée par Monteverde & Associates concernant son projet de fusion avec Almaviva S.p.A. Selon l'accord de fusion, les actions Iteris seront converties en droit de recevoir 7,20 $ en liquide par action. Le cabinet d'enquête note avoir récupéré des fonds pour des actionnaires dans des affaires antérieures et propose une évaluation gratuite sans obligation.
Les investisseurs devraient noter la proposition de 7,20 $ en liquidités et qu'une enquête indépendante est en cours, ce qui pourrait influencer le calendrier de l'accord ou les recours des actionnaires.
Iteris (Nasdaq: ITI) steht im Fokus einer Aktionärsinvestigation von Monteverde & Associates in Bezug auf die geplante Fusion mit Almaviva S.p.A. Gemäss der Fusionsvereinbarung werden Iteris-Aktien in ein Anrecht auf $7,20 Bargeld pro Aktie umgewandelt. Die Untersuchungsfirma erklärt, in früheren Fällen Geld für Aktionäre zurückgeholt zu haben, und bietet eine kostenlose Überprüfung ohne Verpflichtung an.
Investoren sollten die vorgeschlagene $7,20 Bargeld-Vergütung beachten und dass eine Untersuchung durch Dritte läuft, was den Ablauf des Deals oder Rechtsmittel für Aktionäre beeinflussen könnte.
إيتيرس (ناسداك: ITI) هي موضوع تحقيق للمساهمين من قبل Monteverde & Associates فيما يتعلق بالاندماج المقترح مع Almaviva S.p.A. وفق اتفاقية الدمج، ستتم تحويل أسهم إيتيرس إلى حق الحصول على $7.20 نقداً لكل سهم. تشير الشركة التي تجري التحقيق إلى أنها استردت أموال للمساهمين في قضايا سابقة وتقدم مراجعة مجانية بدون التزام.
يجب على المستثمرين ملاحظة المقابل النقدي 7.20$ المقترح وأنه هناك تحقيق طرف ثالث نشط، مما قد يؤثر على توقيت الصفقة أو سبل جبر الضرر للمساهمين.
- Cash consideration of $7.20 per Iteris share
- Clear exit for shareholders via cash conversion
- Third-party investigation into the merger is underway
- Shares will be delisted from public equity upon cash conversion
NEW YORK, Sept. 4, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Iteris, Inc. (Nasdaq: ITI), relating to its proposed merger with Almaviva S.p.A. Under the terms of the agreement, Iteris shares will automatically be converted into the right to receive
Click here for more information: https://monteverdelaw.com/case/iteris-inc/. It is free and there is no cost or obligation to you.
NOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to a lawyer and ask:
- Do you file class actions and go to Court?
- When was the last time you recovered money for shareholders?
- What cases did you recover money in and how much?
About Monteverde & Associates PC
Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court.
No company, director or officer is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.
Contact:
Juan Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341
Attorney Advertising. (C) 2024 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-the-ma-class-action-firm-investigates-the-merger-of-iteris-inc--iti-302238466.html
SOURCE Monteverde & Associates PC
FAQ
What did Monteverde announce about Iteris (ITI) on November 4, 2025?
What will Iteris (ITI) shareholders receive under the proposed merger?
Does the Monteverde investigation affect the Iteris (ITI) merger timeline?
Is there any cost to Iteris (ITI) shareholders contacting the investigating firm?
How can Iteris (ITI) shareholders learn more about the investigation?
